Efficacy of tenofovir-based rescue therapy for chronic hepatitis B patients with resistance to lamivudine and entecavir
Hee-Jeong Jeon, Seok Won Jung, Neung Hwa Park, Yujin Yang, Jin-Hee Noh, Jae-Sung Ahn, Hyung Rae Kim, Jae Ho Lee, Jung Woo Shin
Clin Mol Hepatol. 2017;23(3):230-238.   Published online 2017 Jun 30     DOI: https://doi.org/10.3350/cmh.2017.0003
Citations to this article as recorded by Crossref logo
Effect of tenofovir on renal function in patients with chronic hepatitis B
Woo Jin Jung, Jae Young Jang, Won Young Park, Soung Won Jeong, Hee Jeong Lee, Sang Joon Park, Sae Hwan Lee, Sang Gyune Kim, Sang-Woo Cha, Young Seok Kim, Young Deok Cho, Hong Soo Kim, Boo Sung Kim, Suyeon Park, Baigal Baymbajav
Medicine.2018; 97(7): e9756.     CrossRef
Long-term Outcomes in Patients with HBV Treated with Antiviral Agents
Mauro ViganĂ², Alessandro Loglio, Pietro Lampertico
Current Hepatology Reports.2018; 17(4): 502.     CrossRef
Long-Term Efficacy of Tenofovir Disoproxil Fumarate Monotherapy for Multidrug-Resistant Chronic HBV infection
Hye Won Lee, Jun Yong Park, Jin Woo Lee, Ki Tae Yoon, Chang Wook Kim, Hana Park, Young Seok Kim, Soon Ku Paik, Jung Il Lee, Beom Kyung Kim, Kwang-Hyub Han, Sang Hoon Ahn
Clinical Gastroenterology and Hepatology.2018;[Epub]     CrossRef
Is tenofovir monotherapy a sufficient defense line against multi-drug resistant hepatitis B virus?
Yun Bin Lee, Jeong-Hoon Lee
Clinical and Molecular Hepatology.2017; 23(3): 219.     CrossRef